Related by context. All words. (Click for frequent words.) 62 cytoreductive surgery 62 interventional neuroradiology 61 lymphadenectomy 60 oncological outcomes 60 radiographic outcomes 60 pain palliation 60 extrapleural pneumonectomy 60 nephron sparing surgery 60 Surgical resection 60 endoluminal 59 oncologic outcomes 59 solid organ transplantation 59 oncological 59 sorafenib Nexavar 59 AFRS TM 59 ablative therapy 59 postoperative morbidity 59 anti angiogenic agents 59 tumor resection 59 reimplantation 59 dosimetric 59 endovascular therapy 59 chemoembolization 59 neoadjuvant therapy 59 oral anticoagulation 59 Edwards SAPIEN valve 58 valve implantation 58 carotid artery stenting 58 chemoradiation therapy 58 prospective multicenter study 58 gynecologic procedures 58 chemoradiotherapy 58 hypofractionated 58 adjuvant radiation 58 esophagogastric 58 HIPEC 58 uterine fibroid embolization UFE 58 metastatic RCC 58 clevidipine 58 kidney urologic 58 concurrent chemoradiation 58 nonoperative 58 colorectal liver metastases 58 palliation 58 percutaneous vertebroplasty 58 tumor excision 58 radical cystectomy 58 thoracoscopic lobectomy 58 herpetic keratitis 57 IV NSCLC 57 ADVEXIN therapy 57 p# inhibitor 57 transplantation HCT 57 AF ablation 57 antithrombotic therapy 57 treating cancerous tumors 57 triphendiol 57 metastatic GIST 57 renal transplantation 57 intravesical therapy 57 haematologic 57 Fibrin Pad 57 gastroesophageal junction 57 extracranial 57 metastatic neuroendocrine tumors 57 occlusive disease 57 transurethral resection 57 revision hip arthroplasty 57 microsphere therapy 57 pancreatic adenocarcinoma 57 cytoreduction 57 Combo Stent 57 hepatic metastases 57 urologic surgery 57 angiogenesis inhibition 57 infusional 57 Vascular Wrap TM 57 interventional therapies 57 Trofex 57 HoLEP 57 coronary intervention 57 GI motility disorders 57 percutaneous cryoablation 57 peritoneal carcinomatosis 57 myocardial revascularization 57 intracavitary 57 external beam radiotherapy 57 localized renal 57 SUTENT ® 57 abnormal uterine bleeding 57 IL# PE#QQR 56 transapical approach 56 retroperitoneal 56 lymphatic mapping 56 postoperative pulmonary 56 urology oncology 56 lung resection 56 adjuvant therapies 56 ERCP 56 invasive candidiasis 56 Mohs surgery 56 ELACYT 56 mRCC 56 thromboprophylaxis 56 Proxinium TM 56 oncological indications 56 thymectomy 56 Sudhir Agrawal D.Phil 56 NP2 Enkephalin 56 targeted radiotherapeutic 56 Hepatocellular Carcinoma HCC 56 interventional cardiac 56 haematological cancers 56 pharmacological therapies 56 Interventional radiology 56 hepatobiliary 56 recurrent glioblastoma multiforme 56 Alessandro Riva 56 docetaxel Taxotere ® 56 endocrine therapies 56 IORT 56 colorectal cancer liver metastases 56 pharmacologic stress 56 lumbar spinal fusion 56 relapsed ovarian cancer 56 fibrotic disease 56 genitourinary cancers 56 GEM OS2 56 prostate cancer CRPC 56 femoral neck fractures 56 biliary tract cancer 56 vinca alkaloid 56 endovascular interventions 56 urography 56 oncology 56 CINQUIL 56 fallopian tube cancers 56 percutaneous drainage 56 ischemic mitral regurgitation 56 NAVISTAR R 56 immune modulating 56 BrachySil TM 56 oncology dermatology 56 mechanical thrombectomy 56 ophthalmology dermatology 56 segmentectomy 56 liver resection 56 allogeneic hematopoietic stem cell 56 clinical 56 sonographically guided 56 prostate TURP 56 transesophageal echocardiography 56 pegylated interferon alfa 2b 56 pharmacoeconomic 56 pancreatic transplantation 56 palliative radiotherapy 56 stereotactic radiation 56 fusion enhancers 56 stereotactic radiotherapy 56 refractory colorectal cancer 56 axillary dissection 56 transarterial 56 LEP ETU 55 interventional radiology 55 Mammosite 55 percutaneous intervention 55 renal tumors 55 transcatheter aortic valve implantation 55 debulking surgery 55 GEM OS1 55 radiochemotherapy 55 radiotherapy RT 55 antiangiogenic agents 55 refractory angina 55 fallopian tube carcinoma 55 transarterial chemoembolization 55 metastatic gastric 55 bronchoscopic 55 INFUSE ® 55 prospective nonrandomized 55 radionuclide therapy 55 nonpharmacologic 55 epidural steroid injections 55 postoperative chemotherapy 55 doxorubicin HCl 55 neurosurgery orthopedics 55 postoperative radiotherapy 55 BioDisc 55 malignant growths 55 Surgical excision 55 Combidex 55 carotid artery stenting CAS 55 Cx# [002] 55 sacral nerve stimulation 55 treat menorrhagia 55 mucinous 55 steroid refractory 55 arteriography 55 cytoreductive nephrectomy 55 esophagectomy 55 aerosolized KL4 surfactant 55 ABVD 55 prostate carcinoma 55 radical prostatectomy RP 55 AQ4N 55 PrevOnco 55 urothelial cancer 55 sipuleucel T 55 malignant pleural mesothelioma 55 transapical 55 Li Fraumeni Syndrome 55 primary hyperparathyroidism 55 metastatic colorectal 55 everolimus eluting stents 55 kinase inhibition 55 vascular insufficiency 55 cediranib 55 urothelial carcinoma 55 ureteral 55 edifoligide E2F Decoy 55 pancreatic carcinoma 55 oropharyngeal candidiasis 55 endovascular aneurysm repair 55 erythropoietic 55 InterStim Therapy 55 peripheral artery 55 Factor VIIa 55 platinum refractory 55 allogeneic hematopoietic cell 55 ophthalmology orthopedics 55 fibrin sealant 55 oral anticoagulant therapy 55 fracture fixation 55 bevacizumab Avastin ® 55 clinically localized prostate 55 resectable 55 postoperative mortality 55 antitumor effect 55 cardiologic 55 paclitaxel poliglumex 55 node dissection 55 therapeutic regimens 55 chemosensitivity 55 immunomodulation 55 interventional oncology 55 abdominal hysterectomy 55 metastatic lymph nodes 55 Advagraf 55 allogenic stem cell 55 elective PCI 55 Genasense ® 55 femoral fractures 55 endothelial keratoplasty 54 liver metastasis 54 radical nephrectomy 54 endovascular repair 54 trabectedin 54 metastatic malignant melanoma 54 transthoracic 54 functional mitral regurgitation 54 MGN# 54 neoadjuvant setting 54 YONDELIS 54 GI endoscopy 54 spinal metastases 54 transfemoral approach 54 osteoid osteoma 54 pharmacodynamic parameters 54 CINTREDEKIN BESUDOTOX 54 trans urethral resection 54 atherosclerotic renal artery stenosis 54 oral talactoferrin 54 anti thrombotic 54 surgical revascularization 54 INTERCEPT platelets 54 myelofibrosis polycythemia vera 54 acetabular fractures 54 invasive aspergillosis 54 Belldegrun 54 Embolization 54 Azedra TM 54 dexanabinol 54 Zemiva TM 54 opioid analgesia 54 wedge resection 54 renal 54 radiotherapeutic 54 uterine fibroid embolization 54 variceal hemorrhage 54 colonoscopic 54 peri operative 54 indibulin 54 esophageal gastric 54 urethral bulking agent 54 Elekta Axesse 54 genitourinary 54 CYT# potent vascular disrupting 54 osteoporotic compression fractures 54 vascular anatomy 54 Vascular Wrap 54 perfusion imaging 54 neuroradiology 54 temsirolimus 54 keratoplasty 54 CBLC# 54 neoadjuvant treatment 54 including eniluracil ADH 54 Neuradiab 54 gastroenterology 54 medically inoperable 54 Aplidin 54 adjuvant radiotherapy 54 transoral 54 metastatic renal cell carcinoma 54 hypervascular tumors 54 RALP 54 nonoperative treatment 54 Kyphoplasty 54 investigational therapies 54 ureteral stents 54 pancreatic islet cell 54 pheochromocytoma 54 lymph node dissection 54 immunobiology 54 gastroenterology urology 54 atrial arrhythmias 54 oxaliplatin Eloxatin 54 tissue perfusion 54 malignant ascites 54 liver transplantation 54 arthroplasty 54 neurogenic bladder 54 bifurcation lesions 54 EBUS FNA 54 cerebral vasospasm 54 antifungal therapy 54 plaque excision systems 54 femoral neck fracture 54 invasive coronary angiography 54 Cellegesic 54 tumoral 54 Elafin 54 cardiac allograft vasculopathy 54 unicompartmental knee 54 noninfectious uveitis 54 treating neuropathic pain 54 pelvic malignancies 54 membranous nephropathy 54 postoperative ileus POI 54 Augment Injectable 54 immunosuppressive therapies 54 transplantation HSCT 54 thyroid nodules 54 spinal disorders 54 catheter occlusion 54 immunologic diseases 54 ureteroscopy 54 cannabinor 54 perioperative morbidity 54 ATIR 54 prognostic indicators 54 carotid artery stent 54 preoperative chemotherapy 54 transfemoral 54 excisional 54 diabetic gastroparesis 54 Vidaza azacitidine 54 constipation OIC 54 stem cell engraftment 54 minimally invasive therapies 54 dermatologic diseases 54 Mitomycin C 54 cystectomy 54 leiomyomas 54 CYPHER R Sirolimus eluting 54 ophthalmology oncology 54 locoregional 54 papillary renal cell carcinoma 54 thromboembolic disease 54 superficial bladder cancer 54 hepatobiliary surgery 54 IMiDs ® compound 54 neointimal hyperplasia 54 anticancer therapy 54 peripheral vasculature 54 endovascular aortic repair 54 hematopathology 54 renal denervation 54 cryosurgery 54 PET CT scanning 54 Panzem R NCD 54 procedural sedation 54 thrombophilia 54 vitreo retinal 54 biliary stones 54 Breast Cancer Assay 54 TEMODAL 54 Hematologic 54 cartilage regeneration 54 radiation therapy SBRT 54 recurrent prostate cancer 54 malabsorptive 53 OvaRex ® MAb 53 percutaneous nephrolithotomy 53 EP #R 53 Val HeFT 53 bovine thrombin 53 haematological 53 Liver transplantation 53 fosbretabulin 53 multimodality imaging 53 interventional vascular 53 mitral valve repair 53 sodium stibogluconate 53 idarubicin 53 Solesta 53 needle aspiration 53 Artelon ® 53 ICD implantation 53 benign prostatic hypertrophy BPH 53 skin sparing mastectomy 53 transcatheter closure 53 parathyroidectomy 53 malignant pheochromocytoma 53 TACE 53 limb lengthening 53 cardiac revascularization 53 thalidomide Thalomid 53 LHRH receptor positive 53 adenomatous 53 Prognostic factors 53 RF ablation 53 Kepivance 53 occlusive 53 coronary CTA 53 ocular inflammation 53 DAPT 53 postoperative AF 53 YONDELIS R 53 TroVax ® 53 Soliris TM eculizumab 53 iliac artery disease 53 gastrointestinal GI 53 vitreoretinal 53 lymphomas leukemias 53 curability 53 endoscopic ultrasound 53 prostate adenocarcinoma 53 laparoscopic colon 53 transurethral 53 abdominal aortic aneurysms AAA 53 electrophysiologic 53 Amrubicin 53 Squalamine 53 Cloretazine 53 immuno modulatory 53 Zybrestat 53 AA Amyloidosis 53 R0 resection 53 angiographic outcomes 53 Electronic Brachytherapy 53 Virulizin ® 53 endoscopic retrograde 53 TURP 53 corneal graft 53 vertebral compression fractures 53 percutaneous ablation 53 interferon ribavirin 53 laparoscopic cholecystectomy 53 posterior cervical 53 antimicrobial prophylaxis 53 allogeneic HSCT 53 hematopoietic cancers 53 enucleation 53 thetreatment 53 tricuspid regurgitation 53 therapeutical 53 Balloon sinuplasty 53 Entereg R 53 retropubic 53 HRPC 53 percutaneous transluminal coronary angioplasty 53 immunological diseases 53 DVT PE 53 VATS lobectomy 53 esophageal candidiasis 53 unresectable tumors 53 frameless radiosurgery 53 Adjuvant chemotherapy 53 acute decompensated heart 53 pharmacotherapeutic 53 thrombolytics 53 interventional cardiovascular 53 chemotherapeutic regimen 53 Radical prostatectomy 53 aortic root replacement 53 depsipeptide 53 chronic LBP 53 thoracic aortic 53 humanised monoclonal antibody 53 post surgical adhesions 53 liposomal doxorubicin 53 pancreatic 53 biologic 53 ankle arthrodesis 53 acadesine 53 autologous hematopoietic stem cell 53 voiding dysfunction 53 epigenetic therapies 53 OZURDEX ® 53 Interventional cardiology 53 polidocanol 53 EGFR mutation positive 53 antireflux surgery 53 CT angiography CTA 53 diagnostic molecular imaging 53 vaginal hysterectomy 53 Accelerated Partial Breast Irradiation 53 cardiac resynchronisation therapy 53 anesthesiology radiology 53 somatostatin analogues 53 cardio renal 53 arterial thrombosis 53 cetuximab Erbitux R 53 tezampanel NGX# 53 CEQ# 53 EBUS 53 intra arterial chemotherapy 53 CYPHER Stent 53 metastatic sarcomas 53 distal radius fractures 53 pulmonary artery banding 53 MYLOTARG 53 operable breast cancer 53 narrow QRS 53 metastatic bone 53 acetonide FA 53 verteporfin 53 embolotherapy 53 limb salvage 53 Alocrest 53 systemic immunosuppressive drugs 53 polycythemia vera essential thrombocythemia 53 discogenic pain 53 neuro vascular 53 laparoscopic technique 53 lenalidomide dexamethasone 53 Mohs micrographic surgery 53 carcinoids 53 postoperative ileus 53 skeletal metastases 53 SNT MC# 53 antimetabolite 53 dacarbazine chemotherapy 53 chemotherapy hormonal therapy 53 FUSILEV enhances 53 Cypher Stent 53 neovascularisation 53 vascular abnormalities 53 Dr. Francesco Rubino 53 diagnostic modality 53 Stereotactic radiosurgery 53 fundoplication 53 treating uterine fibroids 53 ovarian carcinoma 53 aflibercept VEGF Trap 53 urologic surgeons 53 fibrotic disorders 53 LE DT 53 vinorelbine 53 Nexavar sorafenib 53 Stabilimax NZ 53 conformal radiotherapy 53 dermatologic disorders 53 stereotactic radiosurgery SRS 53 vertebral augmentation 53 Allovectin 7 ® 53 artery embolization 53 sentinel lymph node biopsy 53 Neoadjuvant 53 MitraClip device 53 TTF therapy 53 metastatic uveal melanoma 53 intra abdominal infections 53 pharmacodynamic properties 53 epithelial tumors 53 CTO recanalization 53 galiximab 53 Cloretazine R 53 Immunotherapeutic 53 tumor histology 53 curative therapy 53 RIGScan CR 53 lung pancreatic 53 trastuzumab DM1 53 oral prodrug 53 myoma 53 urethroplasty 53 endobronchial 53 valvular 53 ALA PDT 53 coronary carotid 53 taxane refractory 53 resection 53 cardiac ablation procedures 53 renal transplants 53 locoregional recurrence 53 Balloon Sinuplasty 53 urodynamics 53 ß blockers 53 colon resection 53 azacitidine 53 osteochondroma 53 transradial 53 Dacogen injection 53 Neulasta ® 53 ophthalmology dermatology cardiovascular disease 53 metastatic liver 53 vascular interventional 53 Vandetanib 53 therapeutic armamentarium 53 radiographic findings 52 transforaminal 52 malignant lymphomas 52 varicose vein treatment 52 sunitinib malate 52 stent implantation 52 Kantarjian 52 lumbar disk herniation 52 methotrexate therapy 52 gastric carcinoma 52 limb sparing 52 overlapping toxicities 52 postoperative atrial fibrillation 52 Prenatal diagnosis 52 angioplasty stenting 52 tiuxetan 52 AzaSite Plus 52 Nonsurgical 52 percutaneous valve 52 either acutely decompensated 52 carboplatin paclitaxel 52 inotropic therapy 52 paracentesis 52 standard chemotherapy regimens 52 thymic carcinoma 52 AV fistulas 52 Soliris eculizumab 52 hematological diseases 52 cinacalcet 52 Mitral valve repair 52 balloon brachytherapy 52 zoledronic acid Zometa 52 photo ablating 52 Xyfid 52 antiangiogenic therapy 52 CoreValve System 52 noninvasive outpatient 52 CA9 SCAN 52 Radiofrequency ablation 52 Liprotamase 52 radioiodine therapy 52 interventional cardiology 52 cisplatin gemcitabine 52 Sanvar R 52 adjuvant trastuzumab 52 GnRH agonists 52 chemotherapeutic regimens 52 endovascular aneurysm repair EVAR 52 metabonomics 52 antithrombotics 52 endovenous laser ablation 52 node metastasis 52 irinotecan chemotherapy 52 calcaneal fractures 52 VALSTAR 52 angiogenic therapy 52 prostate carcinomas 52 NATRECOR ® 52 hip arthroplasty 52 interventional pulmonology 52 adult chronic ITP 52 reversing heparin 52 Yondelis ® 52 bevacizumab Avastin Genentech 52 relapsed SCLC 52 pharmacodynamic markers 52 Pyridorin 52 TLIF 52 bladder augmentation 52 antiplatelet therapies 52 antiarrhythmic drug 52 metastatic malignant 52 surgical debulking 52 FVIIa 52 bifurcation stent 52 AERx R 52 osteoarthritic pain 52 coronary stenting 52 proliferative disorders 52 hypertrophic scars 52 TAXUS Liberte Stent 52 tubulin inhibitor 52 Manja Bouman CEO 52 AERx ® 52 oral dnaJP1 52 gastric adenocarcinoma 52 Chemophase 52 experimental therapeutics 52 nosocomial pneumonia 52 prokinetic agent 52 heparins 52 neo adjuvant 52 budesonide foam 52 Lumbar Interbody Fusion 52 LLLT 52 KRAS mutations occur 52 ischemic cardiac 52 antibiotic prophylaxis 52 Acute Radiation Syndrome 52 preoperative diagnosis 52 MYCAMINE 52 EGFR tyrosine kinase inhibitors 52 pregabalin Lyrica 52 lexidronam injection 52 oxymorphone ER 52 Selective Internal 52 laparoscopic radical prostatectomy 52 nodal metastases 52 paclitaxel eluting stents 52 intravascular 52 fibroma 52 BCG refractory 52 Itopride 52 Cystectomy 52 pouchitis 52 gastric imbrication 52 MAGE A3 ASCI 52 prehospital setting 52 relapsing remitting MS RRMS 52 ocular disorders 52 recurrent metastatic 52 revascularisation 52 robotic prostatectomy 52 β blockers 52 Jeffrey H. Buchalter 52 Coronary artery bypass 52 vivo pharmacology 52 pulmonary toxicity 52 vertebral compression fracture 52 vernakalant hydrochloride 52 PET tracers 52 investigational monoclonal antibody 52 androgen ablation 52 chemotherapy induced neutropenia 52 candidemia 52 IOP lowering 52 patients undergoing CABG 52 extranodal 52 carotid stent 52 Endoscopic Ablation System 52 cannulation 52 knee arthroplasty 52 PDE4 inhibitors 52 Excellagen 52 cytostatic 52 transnasal 52 pretransplant 52 nodal metastasis 52 IRX 2 52 valvular heart 52 immunomodulatory therapy 52 dacarbazine 52 Zenvia ™ 52 uric acid lowering 52 prostate brachytherapy 52 unstable angina UA 52 pamidronate 52 MR arthrography 52 percutaneous aortic valve 52 anti angiogenic drugs 52 gastroduodenal 52 intra arterial 52 micafungin 52 inotropes 52 talabostat 52 pseudophakic 52 PEGylated interferon 52 pulmonary resection 52 superficial femoral 52 Burch colposuspension 52 ReValving 52 adjuvant systemic 52 defibrillator implantation 52 neoplastic 52 Vicinium TM 52 deferiprone 52 tanespimycin 52 aetiology 52 MRgFUS 52 robotic radical prostatectomy 52 intra abdominal abscess 52 Tissue Matrix 52 blood clot dissolving 52 Temsirolimus 52 anthracycline taxane 52 hereditary deficiency 52 neoplastic diseases 52 Kamada AAT 52 endovascular procedures 52 refractory ovarian cancer 52 symptomatic uterine fibroids 52 intraperitoneal chemotherapy 52 R Saizen R 52 pharmacokinetic PK study 52 chronic thromboembolic pulmonary 52 dyslipidemias 52 zotarolimus 52 endoscopic surgical 52 computed tomographic 52 sulodexide 52 acute coronary syndromes ACS 52 TEVAR 52 radiation therapy 52 Solazed 52 oral antiplatelet 52 malignant neoplasms 52 dopaminergic therapy 52 invasive cardiology 52 ALND 52 chemoresistant 52 spontaneous regression 52 ospemifene 52 Percutaneous Transluminal Coronary Angioplasty 52 thymoma 52 prognostic biomarker 52 coronary bypass graft 52 potency selectivity 52 fulvestrant 52 MMP inhibitors 52 otology 52 liquid embolic 52 cangrelor 52 calcineurin inhibitor 52 vascular biology 52 Phase IIb clinical trials 52 sodium thiosulfate STS 52 sacral neuromodulation 52 adipose derived stem cell 52 phakic IOL 52 trastuzumab DM1 T DM1 52 adrenalectomy 52 drug eluting stent DES 52 Arteriovenous 52 haematological malignancies 52 MGd 52 venous leg 52 Onalta TM 52 EDEMA3 trial 52 phase IIb clinical 52 aortic root aneurysm 52 craniomaxillofacial 52 riociguat 52 relapsed leukemia 52 dorzolamide 52 Helicobacter pylori eradication 52 ESBA# 52 perioperative complications 52 antimitotic 52 patients undergoing noncardiac 52 deformity correction 52 photocoagulation 52 biomarker identification 52 overactive bladder syndrome 52 sacrocolpopexy 52 prognostically 52 thrombogenic 52 Src inhibitors 52 histologic findings 52 extracorporeal circulation 52 gemcitabine Gemzar 52 BRAF inhibitor 52 pT2 52 Prodarsan R 52 myeloproliferative disorders 52 pelvic lymph node dissection 52 OvaRex MAb 52 oral Hycamtin 52 peripherally acting 52 coronary stent merged 52 cardiology neurology 52 postsurgical 52 venous thromboembolic disease 52 pharmacologic therapies 52 radiolabeled TM# 52 recurrent glioma 52 produces radioisotopes 52 orthopedics neurology 51 Prostacyclin 51 percutaneous catheter 51 bevacizumab Avastin 51 DEEP AF 51 NovoTTF 51 CR# vcMMAE 51 parathyroid 51 symptomatic carotid stenosis 51 endovascular neurosurgery 51 personalized immunotherapy 51 atrial fibrillation ablation 51 maxillo facial surgery 51 platelet gel 51 secondary hyperparathyroidism 51 mTOR inhibitors 51 bone scintigraphy 51 gynaecologic 51 chronic hemodialysis 51 complement inhibitor eculizumab 51 Acute Coronary Syndromes ACS 51 Altrazeal 51 Ketotransdel TM 51 GP IIb IIIa inhibitors 51 Endoscopic ultrasound 51 chronic ITP patients 51 nephrology urology 51 daptomycin 51 unicompartmental knee replacement 51 stem cell transplantations 51 intradermal injection 51 surgical oncology 51 surgical 51 thrombolytic agents 51 recurrent GBM 51 multiple myeloma MM 51 HNSCC 51 Octreolin 51 Pazopanib 51 thoracentesis 51 Evoltra ® 51 interventional radiology procedures 51 plain radiographs 51 ONCONASE R 51 subconjunctival injection 51 SCCHN 51 immuno inflammatory 51 pericardial effusion 51 chronic GVHD 51 Xanafide 51 rFVIIa 51 autologous bone marrow 51 Cooled ThermoTherapy 51 corneal ectasia 51 graft patency 51 heparin induced thrombocytopenia 51 Stereotactic Body Radiation Therapy 51 adipose derived stem cells 51 radiation sensitizer 51 NEUMUNE 51 cervical lymph nodes 51 osteogenic 51 zanolimumab 51 posttraumatic arthritis 51 paroxysmal AF 51 platinum chromium PROMUS 51 intrathoracic 51 chemotherapy cisplatin 51 demonstrated antitumor activity 51 neoadjuvant 51 nonsurgical treatment 51 trabeculectomy 51 micrometastasis 51 gastrointestinal cancers 51 endoscopic ultrasonography 51 Vascugel 51 KL4 surfactant 51 bioprosthetic valve 51 helical TomoTherapy 51 Benign Prostatic Hyperplasia BPH 51 endovascular stent graft 51 IAP inhibitor 51 cardiac perfusion 51 antiangiogenic drugs 51 nephrectomies 51 CMV disease 51 REG1 51 FOLFOX4 51 gefitinib Iressa 51 Fibrillex TM 51 multislice CT 51 neurology cardiology 51 invasive angiography 51 Doxil ® 51 benign neoplasms 51 NEUGENE antisense 51 neuroprotective agent 51 Intra arterial 51 incontinence erectile dysfunction 51 calcineurin inhibitors 51 preclinical efficacy 51 carotid surgery